These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29679493)

  • 41. The Emerging Role of Quercetin in the Treatment of Chronic Pain.
    Liu C; Liu DQ; Tian YK; Mei W; Tian XB; Xu AJ; Zhou YQ
    Curr Neuropharmacol; 2022 Nov; 20(12):2346-2353. PubMed ID: 35959909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of chronic neuropathic pain with single and compounded topical analgesics.
    Knezevic NN; Tverdohleb T; Nikibin F; Knezevic I; Candido KD
    Pain Manag; 2017 Nov; 7(6):537-558. PubMed ID: 29125423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune cell trafficking, lymphatics and hypertension.
    Balasubbramanian D; Lopez Gelston CA; Rutkowski JM; Mitchell BM
    Br J Pharmacol; 2019 Jun; 176(12):1978-1988. PubMed ID: 29797446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.
    Liao HH; Jia XH; Liu HJ; Yang Z; Tang QZ
    Curr Pharm Des; 2017; 23(11):1677-1686. PubMed ID: 27779079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropathic pain: models and mechanisms.
    Jarvis MF; Boyce-Rustay JM
    Curr Pharm Des; 2009; 15(15):1711-6. PubMed ID: 19442185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex bias in preclinical research and an exploration of how to change the status quo.
    Karp NA; Reavey N
    Br J Pharmacol; 2019 Nov; 176(21):4107-4118. PubMed ID: 30418665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.
    Khuchua Z; Glukhov AI; Strauss AW; Javadov S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic prospects of PPARs in psychiatric disorders: a comprehensive review.
    Rolland B; Deguil J; Jardri R; Cottencin O; Thomas P; Bordet R
    Curr Drug Targets; 2013 Jun; 14(7):724-32. PubMed ID: 23531161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine.
    Hansen HS; Vana V
    Br J Pharmacol; 2019 May; 176(10):1443-1454. PubMed ID: 29473944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxisome proliferator-activated receptors as therapeutic targets for heart failure.
    Abushouk AI; El-Husseny MWA; Bahbah EI; Elmaraezy A; Ali AA; Ashraf A; Abdel-Daim MM
    Biomed Pharmacother; 2017 Nov; 95():692-700. PubMed ID: 28886529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical Analgesics.
    Stanos S
    Phys Med Rehabil Clin N Am; 2020 May; 31(2):233-244. PubMed ID: 32279726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [PPARs: structure, mechanisms of action and control. Note I].
    Filip-Ciubotaru F; Foia L; Manciuc C; Grigore C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):477-84. PubMed ID: 21870744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.
    Genini D; Catapano CV
    J Recept Signal Transduct Res; 2006; 26(5-6):679-92. PubMed ID: 17118805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain.
    Tao W; Zhou W; Wang Y; Sun T; Wang H; Zhang Z; Jin Y
    Neuroscience; 2016 Dec; 339():54-63. PubMed ID: 27646288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacotherapy of chronic neuropathic pain].
    Otto J; Forstenpointner J; Binder A; Baron R
    Internist (Berl); 2019 Jul; 60(7):711-723. PubMed ID: 31187164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The HDAC1/c-JUN complex is essential in the promotion of nerve injury-induced neuropathic pain through JNK signaling.
    Sanna MD; Galeotti N
    Eur J Pharmacol; 2018 Apr; 825():99-106. PubMed ID: 29477655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Translation of drug effects from experimental models of neuropathic pain and analgesia to humans.
    Taneja A; Di Iorio VL; Danhof M; Della Pasqua O
    Drug Discov Today; 2012 Aug; 17(15-16):837-49. PubMed ID: 22445930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Connexins in Chronic Pain and Their Potential as Therapeutic Targets for Next-Generation Analgesics.
    Morioka N; Nakamura Y; Zhang FF; Hisaoka-Nakashima K; Nakata Y
    Biol Pharm Bull; 2019; 42(6):857-866. PubMed ID: 31155584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P; Fruchart JC; Staels B
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.